We are proud of our Exelixis volunteers who took time to support causes close to their hearts this month. See what they’ve been up to: ◾️Worked with Kids Bike Lane to build bikes for teens at the Alameda Boys and Girls Club ◾️Assembled Welcome Back to School teacher desk kits for Oakland Unified School District, Alameda Unified School District and NORRISTOWN AREA SCHOOL DISTRICT ◾️Volunteered with animals at Friends of the Alameda Animal Shelter (FAAS)
About us
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/2XXw9w3 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
- Website
-
http://www.exelixis.com
External link for Exelixis
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Alameda, California
- Type
- Public Company
- Founded
- 1994
Locations
-
Primary
1851 Harbor Bay Pkwy
Alameda, California 94502, US
-
640 Freedom Business Center Dr
King of Prussia, Pennsylvania 19406, US
Employees at Exelixis
Updates
-
In honor of National Hispanic Heritage Month, our employee resource group, EXEL Juntos, hosted author Javier Zamora to discuss his book, Solito. We were inspired to hear Javier speak about his migration story from El Salvador to the United States at the age of nine as he presented his New York Times best-selling memoir to us during today's event. #ERG #DEI #HispanicHeritageMonth
-
We’re channeling three decades of scientific insights and expertise into discovering and developing the next generation of cancer therapies. Because every day counts. #WorldCancerResearchDay
-
Please join the Kidney Cancer Association for their annual Virtual Patient Symposium on Saturday, September 21st! Registration is free and the symposium will bring leading kidney cancer experts directly to patients, caregivers, family members, and anyone looking to learn more about kidney cancer. Topics include Kidney Cancer 101, Caregiving Essentials, and more. #VPS24 For more details and to register, visit https://bit.ly/4cgsUnQ.
-
Final results from phase 3 CABINET pivotal study of our flagship therapy in patients with advanced #NeuroendocrineTumors (NET) presented at #ESMO24 and published in the NEJM Group. Read more in our press release here: https://bit.ly/3zaSzRn.
-
Final overall survival results from phase 3 CONTACT-02 pivotal study evaluating our flagship product in combination with immunotherapy in patients with previously treated advanced #ProstateCancer presented at #ESMO24. Learn more: https://bit.ly/3zkbr08
-
Whether our employees are planning an upcoming vacation, booking a reservation or scheduling home improvements, we have benefits to take the stress out of these tasks, so they can focus on quality time with their families. Learn more about our benefit offerings: https://bit.ly/4dYxZT9. #WhyWeExel
-
Please join us in welcoming the newest members of our team! Each new hire brings a wealth of information and experience to their respective roles, and we look forward to watching them succeed at Exelixis. #WhyWeExel
Similar pages
Browse jobs
Stock
EXEL
NASDAQ
20 minutes delay
$26.66
0.42 (1.601%)
- Open
- 26.27
- Low
- 26.25
- High
- 26.73
Data from Refinitiv
See more info on